Drug approval-patent link system that delays market entry of generic drugs doesn’t seem to imperil pharmaceutical industry
The report 'status and performance of 2 years implementation of Korea-US FTA’ published in recent by Korea Institute for International Economic Policy states that drug approval-patent link system plays a role that delays market entry of generic drugs but implication would be restrictive.
Since ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
